nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—eye—Behcet's disease	0.0497	0.102	CbGeAlD
Naloxone—CREB1—mouth—Behcet's disease	0.0344	0.0707	CbGeAlD
Naloxone—CREB1—brainstem—Behcet's disease	0.0225	0.0462	CbGeAlD
Naloxone—CREB1—eye—Behcet's disease	0.0219	0.0449	CbGeAlD
Naloxone—CREB1—retina—Behcet's disease	0.0217	0.0445	CbGeAlD
Naloxone—TLR4—brain—Behcet's disease	0.0205	0.042	CbGeAlD
Naloxone—TLR4—Toll Like Receptor 4 (TLR4) Cascade—ITGB2—Behcet's disease	0.0202	0.0394	CbGpPWpGaD
Naloxone—CREB1—skin of body—Behcet's disease	0.019	0.0391	CbGeAlD
Naloxone—TLR4—Toll-Like Receptors Cascades—ITGB2—Behcet's disease	0.018	0.0351	CbGpPWpGaD
Naloxone—CREB1—mammalian vulva—Behcet's disease	0.0174	0.0357	CbGeAlD
Naloxone—ESR1—blood vessel—Behcet's disease	0.0162	0.0332	CbGeAlD
Naloxone—CREB1—medulla oblongata—Behcet's disease	0.0157	0.0322	CbGeAlD
Naloxone—CREB1—midbrain—Behcet's disease	0.0143	0.0294	CbGeAlD
Naloxone—CREB1—spinal cord—Behcet's disease	0.014	0.0287	CbGeAlD
Naloxone—OPRM1—brainstem—Behcet's disease	0.0121	0.0249	CbGeAlD
Naloxone—CREB1—nervous system—Behcet's disease	0.0118	0.0242	CbGeAlD
Naloxone—CREB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.0115	0.0225	CbGpPWpGaD
Naloxone—CREB1—central nervous system—Behcet's disease	0.0113	0.0233	CbGeAlD
Naloxone—OPRD1—Peptide GPCRs—CCR1—Behcet's disease	0.011	0.0215	CbGpPWpGaD
Naloxone—CREB1—Interferon type I signaling pathways—STAT4—Behcet's disease	0.00976	0.019	CbGpPWpGaD
Naloxone—OPRK1—Peptide GPCRs—CCR1—Behcet's disease	0.00966	0.0188	CbGpPWpGaD
Naloxone—OPRD1—nervous system—Behcet's disease	0.00931	0.0191	CbGeAlD
Naloxone—ABCB1—Allograft Rejection—MICA—Behcet's disease	0.00913	0.0178	CbGpPWpGaD
Naloxone—CREB1—brain—Behcet's disease	0.009	0.0185	CbGeAlD
Naloxone—OPRD1—central nervous system—Behcet's disease	0.00896	0.0184	CbGeAlD
Naloxone—OPRK1—nervous system—Behcet's disease	0.00893	0.0183	CbGeAlD
Naloxone—ESR1—brainstem—Behcet's disease	0.00885	0.0182	CbGeAlD
Naloxone—TLR4—Innate Immune System—MEFV—Behcet's disease	0.00884	0.0172	CbGpPWpGaD
Naloxone—OPRK1—central nervous system—Behcet's disease	0.00859	0.0176	CbGeAlD
Naloxone—OPRM1—Peptide GPCRs—CCR1—Behcet's disease	0.00817	0.0159	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—ICAM1—Behcet's disease	0.00774	0.0151	CbGpPWpGaD
Naloxone—OPRM1—midbrain—Behcet's disease	0.00772	0.0159	CbGeAlD
Naloxone—OPRM1—spinal cord—Behcet's disease	0.00754	0.0155	CbGeAlD
Naloxone—TLR4—Corticotropin-releasing hormone—NOS3—Behcet's disease	0.00753	0.0147	CbGpPWpGaD
Naloxone—SLCO1A2—medulla oblongata—Behcet's disease	0.00728	0.0149	CbGeAlD
Naloxone—OPRD1—brain—Behcet's disease	0.00712	0.0146	CbGeAlD
Naloxone—CREB1—Toll Like Receptor 4 (TLR4) Cascade—ITGB2—Behcet's disease	0.00705	0.0137	CbGpPWpGaD
Naloxone—OPRK1—brain—Behcet's disease	0.00682	0.014	CbGeAlD
Naloxone—TLR4—Corticotropin-releasing hormone—CXCL8—Behcet's disease	0.00668	0.013	CbGpPWpGaD
Naloxone—SLCO1A2—midbrain—Behcet's disease	0.00665	0.0137	CbGeAlD
Naloxone—ALB—Scavenging of heme from plasma—APOA1—Behcet's disease	0.00657	0.0128	CbGpPWpGaD
Naloxone—SLCO1A2—spinal cord—Behcet's disease	0.00649	0.0133	CbGeAlD
Naloxone—ABCB1—blood vessel—Behcet's disease	0.00639	0.0131	CbGeAlD
Naloxone—OPRM1—nervous system—Behcet's disease	0.00635	0.013	CbGeAlD
Naloxone—CREB1—Toll-Like Receptors Cascades—ITGB2—Behcet's disease	0.00628	0.0122	CbGpPWpGaD
Naloxone—CREB1—FOXA2 and FOXA3 transcription factor networks—APOA1—Behcet's disease	0.00626	0.0122	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.00615	0.012	CbGpPWpGaD
Naloxone—OPRM1—central nervous system—Behcet's disease	0.00611	0.0126	CbGeAlD
Naloxone—CREB1—Interleukin-11 Signaling Pathway—ICAM1—Behcet's disease	0.00595	0.0116	CbGpPWpGaD
Naloxone—ALB—HDL-mediated lipid transport—APOA1—Behcet's disease	0.00585	0.0114	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—ITGB2—Behcet's disease	0.00583	0.0114	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—CXCL8—Behcet's disease	0.00547	0.0107	CbGpPWpGaD
Naloxone—SLCO1A2—nervous system—Behcet's disease	0.00547	0.0112	CbGeAlD
Naloxone—CREB1—AP-1 transcription factor network—IL10—Behcet's disease	0.00531	0.0103	CbGpPWpGaD
Naloxone—SLCO1A2—central nervous system—Behcet's disease	0.00526	0.0108	CbGeAlD
Naloxone—OPRD1—Peptide ligand-binding receptors—CCR1—Behcet's disease	0.00518	0.0101	CbGpPWpGaD
Naloxone—ESR1—FOXA1 transcription factor network—APOB—Behcet's disease	0.00518	0.0101	CbGpPWpGaD
Naloxone—TLR4—Immune System—MEFV—Behcet's disease	0.00515	0.01	CbGpPWpGaD
Naloxone—CREB1—Transcription factor regulation in adipogenesis—TNF—Behcet's disease	0.0051	0.00994	CbGpPWpGaD
Naloxone—OPRM1—brain—Behcet's disease	0.00485	0.00997	CbGeAlD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.0048	0.00936	CbGpPWpGaD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—IL10—Behcet's disease	0.00472	0.00921	CbGpPWpGaD
Naloxone—ESR1—nervous system—Behcet's disease	0.00464	0.00952	CbGeAlD
Naloxone—TLR4—Immune System—ERAP1—Behcet's disease	0.00459	0.00894	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—CCR1—Behcet's disease	0.00455	0.00886	CbGpPWpGaD
Naloxone—ESR1—central nervous system—Behcet's disease	0.00446	0.00916	CbGeAlD
Naloxone—OPRD1—G alpha (i) signalling events—CCR1—Behcet's disease	0.00437	0.00853	CbGpPWpGaD
Naloxone—OPRM1—IL4-mediated signaling events—IL10—Behcet's disease	0.00432	0.00842	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	0.00428	0.00835	CbGpPWpGaD
Naloxone—ALB—Lipoprotein metabolism—APOB—Behcet's disease	0.00425	0.00829	CbGpPWpGaD
Naloxone—SLCO1A2—brain—Behcet's disease	0.00418	0.00858	CbGeAlD
Naloxone—CREB1—Circadian Clock—SERPINE1—Behcet's disease	0.00416	0.0081	CbGpPWpGaD
Naloxone—ALB—brain—Behcet's disease	0.00415	0.00853	CbGeAlD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.00406	0.00791	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.00399	0.00779	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CCR1—Behcet's disease	0.00384	0.00749	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—CCR1—Behcet's disease	0.00383	0.00748	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—TNF—Behcet's disease	0.00381	0.00743	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—SERPINE1—Behcet's disease	0.00364	0.00709	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—ICAM1—Behcet's disease	0.00361	0.00705	CbGpPWpGaD
Naloxone—CREB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.00359	0.007	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.00356	0.00694	CbGpPWpGaD
Naloxone—ESR1—brain—Behcet's disease	0.00354	0.00728	CbGeAlD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.00348	0.00678	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—IL10—Behcet's disease	0.00348	0.00678	CbGpPWpGaD
Naloxone—TLR4—Immune System—ITGB2—Behcet's disease	0.00339	0.00662	CbGpPWpGaD
Naloxone—ABCB1—retina—Behcet's disease	0.00337	0.00692	CbGeAlD
Naloxone—ALB—Lipoprotein metabolism—APOA1—Behcet's disease	0.00336	0.00656	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	0.00334	0.00652	CbGpPWpGaD
Naloxone—CREB1—ATF-2 transcription factor network—CXCL8—Behcet's disease	0.00333	0.00649	CbGpPWpGaD
Naloxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOB—Behcet's disease	0.00331	0.00645	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—NOS3—Behcet's disease	0.00329	0.00641	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—CCR1—Behcet's disease	0.00324	0.00632	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—NOS3—Behcet's disease	0.0031	0.00604	CbGpPWpGaD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—Behcet's disease	0.00309	0.00603	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—MEFV—Behcet's disease	0.00308	0.00601	CbGpPWpGaD
Naloxone—TLR4—Immune System—ITGAL—Behcet's disease	0.00306	0.00597	CbGpPWpGaD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—Behcet's disease	0.00305	0.00594	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.00305	0.00594	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.00301	0.00586	CbGpPWpGaD
Naloxone—CYP2C8—brain—Behcet's disease	0.00292	0.00599	CbGeAlD
Naloxone—CREB1—AP-1 transcription factor network—CXCL8—Behcet's disease	0.0029	0.00566	CbGpPWpGaD
Naloxone—ALB—Lipid and lipoprotein metabolism—APOB—Behcet's disease	0.00282	0.00551	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL10—Behcet's disease	0.0028	0.00545	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—APOB—Behcet's disease	0.00278	0.00542	CbGpPWpGaD
Naloxone—ABCB1—mammalian vulva—Behcet's disease	0.0027	0.00554	CbGeAlD
Naloxone—TLR4—Innate Immune System—HLA-B—Behcet's disease	0.00268	0.00522	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CCR1—Behcet's disease	0.00265	0.00516	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ERAP1—Behcet's disease	0.00264	0.00515	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—NOS3—Behcet's disease	0.00263	0.00513	CbGpPWpGaD
Naloxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—Behcet's disease	0.00262	0.00511	CbGpPWpGaD
Naloxone—CYP3A4—nervous system—Behcet's disease	0.00259	0.00531	CbGeAlD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.00258	0.00502	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—CXCL8—Behcet's disease	0.00256	0.00498	CbGpPWpGaD
Naloxone—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.00255	0.00496	CbGpPWpGaD
Naloxone—CYP3A4—central nervous system—Behcet's disease	0.00249	0.00511	CbGeAlD
Naloxone—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—Behcet's disease	0.00248	0.00483	CbGpPWpGaD
Naloxone—ABCB1—medulla oblongata—Behcet's disease	0.00244	0.005	CbGeAlD
Naloxone—CREB1—DAP12 interactions—HLA-B—Behcet's disease	0.0024	0.00469	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—CXCL8—Behcet's disease	0.00233	0.00455	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—CAT—Behcet's disease	0.00233	0.00454	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CCR1—Behcet's disease	0.00232	0.00453	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—APOB—Behcet's disease	0.00226	0.00441	CbGpPWpGaD
Naloxone—ALB—Lipid and lipoprotein metabolism—APOA1—Behcet's disease	0.00223	0.00436	CbGpPWpGaD
Naloxone—ABCB1—midbrain—Behcet's disease	0.00223	0.00457	CbGeAlD
Naloxone—ALB—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.0022	0.00429	CbGpPWpGaD
Naloxone—ESR1—ATF-2 transcription factor network—CXCL8—Behcet's disease	0.00218	0.00425	CbGpPWpGaD
Naloxone—ABCB1—spinal cord—Behcet's disease	0.00217	0.00446	CbGeAlD
Naloxone—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	0.00215	0.00419	CbGpPWpGaD
Naloxone—TLR4—Immune System—CTLA4—Behcet's disease	0.00211	0.00411	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.00209	0.00407	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—SERPINE1—Behcet's disease	0.00209	0.00407	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—ITGB2—Behcet's disease	0.00203	0.00397	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—NOS3—Behcet's disease	0.00203	0.00395	CbGpPWpGaD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—Behcet's disease	0.002	0.00389	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CCR1—Behcet's disease	0.00196	0.00383	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ITGB2—Behcet's disease	0.00195	0.00381	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—CXCL8—Behcet's disease	0.0019	0.00371	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.00185	0.00361	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—CAT—Behcet's disease	0.00185	0.00361	CbGpPWpGaD
Naloxone—ABCB1—nervous system—Behcet's disease	0.00183	0.00376	CbGeAlD
Naloxone—ALB—Selenium Micronutrient Network—APOB—Behcet's disease	0.0018	0.0035	CbGpPWpGaD
Naloxone—CREB1—Immune System—MEFV—Behcet's disease	0.0018	0.0035	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—APOA1—Behcet's disease	0.00179	0.00349	CbGpPWpGaD
Naloxone—ABCB1—central nervous system—Behcet's disease	0.00176	0.00362	CbGeAlD
Naloxone—CREB1—Adaptive Immune System—ITGAL—Behcet's disease	0.00176	0.00343	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.00175	0.0034	CbGpPWpGaD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—NOS3—Behcet's disease	0.00173	0.00338	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—ICAM1—Behcet's disease	0.0017	0.00332	CbGpPWpGaD
Naloxone—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.00168	0.00327	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00167	0.00326	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.00167	0.00326	CbGpPWpGaD
Naloxone—CREB1—Immune System—ERAP1—Behcet's disease	0.0016	0.00312	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.00159	0.0031	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-B—Behcet's disease	0.00156	0.00304	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—APOA1—Behcet's disease	0.00153	0.00299	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.00153	0.00298	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CCR1—Behcet's disease	0.0015	0.00292	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—SERPINE1—Behcet's disease	0.00147	0.00287	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.00146	0.00285	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—APOA1—Behcet's disease	0.00142	0.00277	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—SERPINE1—Behcet's disease	0.00142	0.00277	CbGpPWpGaD
Naloxone—ABCB1—brain—Behcet's disease	0.0014	0.00287	CbGeAlD
Naloxone—CREB1—Signaling by GPCR—CCR1—Behcet's disease	0.00136	0.00266	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCR1—Behcet's disease	0.00136	0.00265	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.00135	0.00263	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CCR1—Behcet's disease	0.00131	0.00256	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.0013	0.00254	CbGpPWpGaD
Naloxone—TLR4—Immune System—ICAM1—Behcet's disease	0.00127	0.00247	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.00124	0.00243	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—TNF—Behcet's disease	0.00123	0.0024	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—SERPINE1—Behcet's disease	0.00122	0.00237	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CTLA4—Behcet's disease	0.00121	0.00236	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCR1—Behcet's disease	0.00119	0.00232	CbGpPWpGaD
Naloxone—CREB1—Immune System—ITGB2—Behcet's disease	0.00118	0.00231	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00116	0.00226	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.00114	0.00222	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.00113	0.0022	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CCR1—Behcet's disease	0.00111	0.00216	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—CXCL8—Behcet's disease	0.0011	0.00214	CbGpPWpGaD
Naloxone—CREB1—Immune System—ITGAL—Behcet's disease	0.00107	0.00208	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—TNF—Behcet's disease	0.00106	0.00207	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—TNF—Behcet's disease	0.00103	0.00201	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCR1—Behcet's disease	0.00101	0.00196	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.000964	0.00188	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—CXCL8—Behcet's disease	0.000963	0.00188	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HLA-B—Behcet's disease	0.000934	0.00182	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000913	0.00178	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000905	0.00176	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-B—Behcet's disease	0.000897	0.00175	CbGpPWpGaD
Naloxone—ALB—Hemostasis—ITGB2—Behcet's disease	0.000894	0.00174	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000873	0.0017	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TNF—Behcet's disease	0.000837	0.00163	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000826	0.00161	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—CXCL8—Behcet's disease	0.000814	0.00159	CbGpPWpGaD
Naloxone—ALB—Hemostasis—ITGAL—Behcet's disease	0.000806	0.00157	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCR1—Behcet's disease	0.000805	0.00157	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCR1—Behcet's disease	0.000803	0.00156	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000786	0.00153	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000765	0.00149	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTLA4—Behcet's disease	0.000735	0.00143	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ICAM1—Behcet's disease	0.000729	0.00142	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR1—Behcet's disease	0.000704	0.00137	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000681	0.00133	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—TNF—Behcet's disease	0.000665	0.0013	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CXCL8—Behcet's disease	0.000665	0.0013	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000654	0.00127	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000647	0.00126	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000635	0.00124	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000622	0.00121	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR1—Behcet's disease	0.000595	0.00116	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000593	0.00116	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CXCL8—Behcet's disease	0.000583	0.00114	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-B—Behcet's disease	0.000544	0.00106	CbGpPWpGaD
Naloxone—CREB1—Disease—APOB—Behcet's disease	0.000543	0.00106	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.00054	0.00105	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR1—Behcet's disease	0.000527	0.00103	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—SERPINE1—Behcet's disease	0.000499	0.000974	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CXCL8—Behcet's disease	0.000493	0.00096	CbGpPWpGaD
Naloxone—ALB—Hemostasis—APOB—Behcet's disease	0.000443	0.000864	CbGpPWpGaD
Naloxone—CREB1—Immune System—ICAM1—Behcet's disease	0.000442	0.000862	CbGpPWpGaD
Naloxone—CREB1—Disease—APOA1—Behcet's disease	0.000429	0.000837	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—Behcet's disease	0.000423	0.000825	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000406	0.000791	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000404	0.000787	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000384	0.000748	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APOB—Behcet's disease	0.00038	0.000741	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CAT—Behcet's disease	0.000379	0.000739	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APOB—Behcet's disease	0.000379	0.000739	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000376	0.000732	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—APOB—Behcet's disease	0.000368	0.000717	CbGpPWpGaD
Naloxone—ALB—Hemostasis—APOA1—Behcet's disease	0.000351	0.000684	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CXCL8—Behcet's disease	0.000342	0.000667	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CXCL8—Behcet's disease	0.000341	0.000665	CbGpPWpGaD
Naloxone—CREB1—Disease—SERPINE1—Behcet's disease	0.000341	0.000665	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000336	0.000656	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APOB—Behcet's disease	0.000332	0.000648	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000329	0.000642	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS3—Behcet's disease	0.000325	0.000634	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000321	0.000626	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000319	0.000623	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000314	0.000611	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000304	0.000592	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APOA1—Behcet's disease	0.000301	0.000586	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APOA1—Behcet's disease	0.0003	0.000584	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CXCL8—Behcet's disease	0.000299	0.000583	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—APOA1—Behcet's disease	0.000291	0.000568	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APOB—Behcet's disease	0.000281	0.000547	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SERPINE1—Behcet's disease	0.000278	0.000543	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000278	0.000543	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000266	0.000519	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS3—Behcet's disease	0.000266	0.000518	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APOA1—Behcet's disease	0.000263	0.000512	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CXCL8—Behcet's disease	0.000253	0.000493	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APOB—Behcet's disease	0.000249	0.000485	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—SERPINE1—Behcet's disease	0.00024	0.000469	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SERPINE1—Behcet's disease	0.000239	0.000465	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SERPINE1—Behcet's disease	0.000238	0.000464	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOS3—Behcet's disease	0.000228	0.000444	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOS3—Behcet's disease	0.000227	0.000443	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APOA1—Behcet's disease	0.000222	0.000433	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—NOS3—Behcet's disease	0.000221	0.00043	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SERPINE1—Behcet's disease	0.000209	0.000407	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CXCL8—Behcet's disease	0.000202	0.000394	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CXCL8—Behcet's disease	0.000201	0.000393	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOS3—Behcet's disease	0.000199	0.000388	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APOA1—Behcet's disease	0.000197	0.000384	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CAT—Behcet's disease	0.000186	0.000363	CbGpPWpGaD
Naloxone—ALB—Metabolism—CAT—Behcet's disease	0.000185	0.000361	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOB—Behcet's disease	0.000181	0.000352	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOB—Behcet's disease	0.00018	0.00035	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCL8—Behcet's disease	0.000177	0.000344	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SERPINE1—Behcet's disease	0.000176	0.000344	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOS3—Behcet's disease	0.000168	0.000328	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CAT—Behcet's disease	0.000162	0.000316	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOB—Behcet's disease	0.000158	0.000307	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SERPINE1—Behcet's disease	0.000156	0.000305	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCL8—Behcet's disease	0.000149	0.000291	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOS3—Behcet's disease	0.000149	0.000291	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOA1—Behcet's disease	0.000143	0.000279	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOA1—Behcet's disease	0.000142	0.000277	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL8—Behcet's disease	0.000132	0.000258	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOA1—Behcet's disease	0.000125	0.000243	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NOS3—Behcet's disease	0.000108	0.000211	CbGpPWpGaD
Naloxone—ALB—Metabolism—NOS3—Behcet's disease	0.000108	0.00021	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CAT—Behcet's disease	0.0001	0.000195	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOB—Behcet's disease	9.7e-05	0.000189	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NOS3—Behcet's disease	9.44e-05	0.000184	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOA1—Behcet's disease	7.68e-05	0.00015	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NOS3—Behcet's disease	5.82e-05	0.000113	CbGpPWpGaD
